Antonio Curti

8.2k total citations · 1 hit paper
156 papers, 5.2k citations indexed

About

Antonio Curti is a scholar working on Hematology, Immunology and Molecular Biology. According to data from OpenAlex, Antonio Curti has authored 156 papers receiving a total of 5.2k indexed citations (citations by other indexed papers that have themselves been cited), including 75 papers in Hematology, 61 papers in Immunology and 36 papers in Molecular Biology. Recurrent topics in Antonio Curti's work include Acute Myeloid Leukemia Research (52 papers), Immune Cell Function and Interaction (36 papers) and Hematopoietic Stem Cell Transplantation (31 papers). Antonio Curti is often cited by papers focused on Acute Myeloid Leukemia Research (52 papers), Immune Cell Function and Interaction (36 papers) and Hematopoietic Stem Cell Transplantation (31 papers). Antonio Curti collaborates with scholars based in Italy, United Kingdom and United States. Antonio Curti's co-authors include Roberto M. Lemoli, Michele Baccarani, Francesco Di Virgilio, Elena Adinolfi, Valentina Salvestrini, Marco Idzko, Davide Ferrari, Elisabeth Panther, Cinzia Pizzirani and Sara Trabanelli and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and The EMBO Journal.

In The Last Decade

Antonio Curti

140 papers receiving 5.1k citations

Hit Papers

The P2X7 Receptor: A Key Player in IL-1 Processing and Re... 2006 2026 2012 2019 2006 250 500 750
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. The P2X7 Receptor: A Key Player in IL-1 Processing and Release
    2006 880 citations Elena Adinolfi, Roberto M. Lemoli et al. The Journal of Immunology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Antonio Curti Italy 36 2.4k 1.4k 1.3k 1.2k 901 156 5.2k
Roberto M. Lemoli Italy 48 3.1k 1.3× 2.9k 2.1× 2.1k 1.5× 1.8k 1.5× 972 1.1× 239 7.7k
Alberto L. Horenstein Italy 32 1.4k 0.6× 707 0.5× 1.1k 0.8× 1.2k 1.0× 1.9k 2.2× 76 4.1k
Akio Ohta Japan 22 2.8k 1.2× 1.3k 0.9× 1.2k 0.9× 915 0.7× 1.4k 1.5× 81 5.5k
Katsuhiko Ishihara Japan 34 2.4k 1.0× 387 0.3× 2.1k 1.5× 1.6k 1.3× 577 0.6× 81 5.8k
Giovanna Borsellino Italy 49 4.6k 1.9× 266 0.2× 2.4k 1.8× 1.3k 1.0× 363 0.4× 105 8.6k
Ada Funaro Italy 35 1.6k 0.7× 473 0.3× 1.2k 0.9× 782 0.6× 1.9k 2.1× 94 5.0k
Olivier Boyer France 43 1.6k 0.7× 354 0.3× 1.9k 1.4× 772 0.6× 427 0.5× 177 5.9k
Jörg Hamann Netherlands 49 3.4k 1.4× 252 0.2× 3.3k 2.5× 907 0.7× 88 0.1× 151 7.7k
Mary C. Nakamura United States 41 3.1k 1.3× 498 0.4× 2.1k 1.5× 942 0.8× 57 0.1× 80 6.1k
Linda F. Thompson United States 46 2.3k 1.0× 302 0.2× 1.9k 1.4× 1.3k 1.0× 4.2k 4.6× 100 7.6k

Countries citing papers authored by Antonio Curti

Since Specialization
Citations

This map shows the geographic impact of Antonio Curti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Antonio Curti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Antonio Curti more than expected).

Fields of papers citing papers by Antonio Curti

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Antonio Curti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Antonio Curti. The network helps show where Antonio Curti may publish in the future.

Co-authorship network of co-authors of Antonio Curti

This figure shows the co-authorship network connecting the top 25 collaborators of Antonio Curti. A scholar is included among the top collaborators of Antonio Curti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Antonio Curti. Antonio Curti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Očadlíková, Darina, Sara Trabanelli, Valentina Salvestrini, et al.. (2025). Noncanonical NF-κB signaling in dendritic cells is required for ATP-driven indoleamine 2,3-dioxygenase 1 induction through P2Y11 receptor. Journal of Leukocyte Biology. 117(4). 1 indexed citations
2.
Barone, Martina, Maria Irno Consalvo, Gabriella Chirumbolo, et al.. (2025). Validation Study of Analytical Methods for Multiparameter Flow Cytometry-Based Measurable Residual Disease Assessment in Acute Myeloid Leukemia. International Journal of Molecular Sciences. 26(10). 4506–4506.
3.
Cortes, Jörge E., Gail J. Roboz, Maria R. Baer, et al.. (2025). Olutasidenib in combination with azacitidine induces durable complete remissions in patients with relapsed or refractory mIDH1 acute myeloid leukemia: a multicohort open-label phase 1/2 trial. Journal of Hematology & Oncology. 18(1). 7–7. 7 indexed citations
4.
Piciocchi, Alfonso, Stefano Soddu, Francesco Buccisano, et al.. (2024). A GIMEMA survey on therapeutic use and response rates of FLT3 inhibitors in acute myeloid leukemia: Insights from Italian real‐world practice. SHILAP Revista de lepidopterología. 5(6). 1274–1277.
5.
Finelli, Carlo, Antonio Curti, Stefania Paolini, et al.. (2024). Signaling pathways and bone marrow microenvironment in myelodysplastic neoplasms. Advances in Biological Regulation. 95. 101071–101071. 2 indexed citations
6.
Daver, Naval, Pau Montesinos, Jessica K. Altman, et al.. (2024). A phase 1b/2 study of pivekimab sunirine (PVEK, IMGN632) in combination with venetoclax/azacitidine for patients with newly diagnosed CD123-positive acute myeloid leukemia.. Journal of Clinical Oncology. 42(16_suppl). TPS6585–TPS6585. 1 indexed citations
7.
Meazza, Raffaella, Loredana Ruggeri, Fabio Guolo, et al.. (2023). Donor selection for adoptive immunotherapy with NK cells in AML patients: Comparison between analysis of lytic NK cell clones and phenotypical identification of alloreactive NK cell repertoire. Frontiers in Immunology. 14. 1111419–1111419. 7 indexed citations
8.
Corradi, Giulia, Barbara Bassani, Giorgia Simonetti, et al.. (2022). Release of IFNγ by Acute Myeloid Leukemia Cells Remodels Bone Marrow Immune Microenvironment by Inducing Regulatory T Cells. Clinical Cancer Research. 28(14). 3141–3155. 35 indexed citations
9.
Tripodo, Claudio, Barbara Bassani, Elena Jachetti, et al.. (2022). Neutrophil extracellular traps arm DC vaccination against NPM-mutant myeloproliferation. eLife. 11. 13 indexed citations
10.
Domingues, Ana Filipa, George Giotopoulos, Aditya Chandru, et al.. (2021). KAT2A complexes ATAC and SAGA play unique roles in cell maintenance and identity in hematopoiesis and leukemia. Blood Advances. 6(1). 165–180. 10 indexed citations
11.
Ciciarello, Marilena, Giulia Corradi, Dorian Forte, Michèle Cavo, & Antonio Curti. (2021). Emerging Bone Marrow Microenvironment-Driven Mechanisms of Drug Resistance in Acute Myeloid Leukemia: Tangle or Chance?. Cancers. 13(21). 5319–5319. 23 indexed citations
12.
Fontana, Maria Chiara, Jacopo Nanni, Andrea Ghelli Luserna di Rorà, et al.. (2021). Pharmacological Inhibition of WIP1 Sensitizes Acute Myeloid Leukemia Cells to the MDM2 Inhibitor Nutlin-3a. Biomedicines. 9(4). 388–388. 9 indexed citations
13.
Forte, Dorian, Flaminia Fanelli, Marco Mezzullo, et al.. (2020). Disease-Specific Derangement of Circulating Endocannabinoids and N-Acylethanolamines in Myeloproliferative Neoplasms. International Journal of Molecular Sciences. 21(9). 3399–3399. 5 indexed citations
14.
Gaibani, Paolo, Chiara Sartor, Simone Ambretti, et al.. (2020). Ceftolozane-Tazobactam Treatment of Hypervirulent Multidrug Resistant Pseudomonas aeruginosa Infections in Neutropenic Patients. Microorganisms. 8(12). 2055–2055. 5 indexed citations
15.
Corradi, Giulia, Carmen Baldazzi, Darina Očadlíková, et al.. (2018). Mesenchymal stromal cells from myelodysplastic and acute myeloid leukemia patients display in vitro reduced proliferative potential and similar capacity to support leukemia cell survival. Stem Cell Research & Therapy. 9(1). 271–271. 69 indexed citations
16.
Forte, Dorian, Marilena Ciciarello, Maria Chiara Valerii, et al.. (2015). Human cord blood-derived platelet lysate enhances the therapeutic activity of adipose-derived mesenchymal stromal cells isolated from Crohn’s disease patients in a mouse model of colitis. Stem Cell Research & Therapy. 6(1). 170–170. 28 indexed citations
17.
Sartor, Chiara, Cristina Papayannidis, Maria Chiara Abbenante, et al.. (2013). A Case Report of Acute Myeloid Leukemia and Neurofibromatosis 1. SHILAP Revista de lepidopterología. 5(2). e8–e8. 2 indexed citations
18.
Trabanelli, Sara, Darina Očadlíková, Cecilia Evangelisti, Sarah Parisi, & Antonio Curti. (2011). Induction of Regulatory T Cells by Dendritic Cells through Indoleamine 2,3- dioxygenase: A Potent Mechanism of Acquired Peripheral Tolerance. Current Medicinal Chemistry. 18(15). 2234–2239. 22 indexed citations
19.
Tazzari, Pier Luigi, Letizia Polito, Andrea Bolognesi, et al.. (2001). Immunotoxins Containing Recombinant Anti-CTLA-4 Single-Chain Fragment Variable Antibodies and Saporin: In Vitro Results and In Vivo Effects in an Acute Rejection Model. The Journal of Immunology. 167(8). 4222–4229. 33 indexed citations
20.
Curti, Antonio, Miriam Fogli, Marina Ratta, S Tura, & Roberto M. Lemoli. (2001). Stem Cell Factor and FLT3-Ligand Are Strictly Required to Sustain the Long-Term Expansion of Primitive CD34+DR− Dendritic Cell Precursors. The Journal of Immunology. 166(2). 848–854. 51 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Roberto M. Lemoli Breakdown of academic impact, for papers by Alberto L. Horenstein Breakdown of academic impact, for papers by Akio Ohta Breakdown of academic impact, for papers by Katsuhiko Ishihara Breakdown of academic impact, for papers by Giovanna Borsellino Breakdown of academic impact, for papers by Ada Funaro Breakdown of academic impact, for papers by Olivier Boyer Breakdown of academic impact, for papers by Jörg Hamann Breakdown of academic impact, for papers by Mary C. Nakamura Breakdown of academic impact, for papers by Linda F. Thompson
Rankless by CCL
2026